Search research articles
Contact Us
Filters
Showing results (91-100 of 241) with videos related to
Page
of 25
Sort By:
Nature
|
March 26, 2005
Recognition of bacterial glycosphingolipids by natural killer T cells
Yuki Kinjo, Douglass Wu, Gisen Kim, et al.
Journal of Virology
|
November 5, 2020
Dual Pathways of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trafficking Modulate the Selective Exclusion of Uncleaved Oligomers from Virions
Shijian Zhang, Hanh T Nguyen, Haitao Ding, et al.
Plos Biology
|
March 14, 2024
Developing inhibitory peptides against SARS-CoV-2 envelope protein
Ramsey Bekdash, Kazushige Yoshida, Manoj S Nair, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2026
LP.8.1-directed COVID-19 mRNA vaccines durably boost neutralizing antibodies and mitigate ancestral immune imprinting
Ian A Mellis, Madeline Wu, Hsiang Hong, et al.
Journal of Virology
|
November 20, 2002
Human immunodeficiency virus type 1 (HIV-1)-specific CD8+-T-cell responses for groups of HIV-1-infected individuals with different HLA-B*35 genotypes
Xia Jin, Xiaojiang Gao, Murugappan Ramanathan, et al.
Plos Pathogens
|
May 11, 2026
LP.8.1-directed COVID-19 mRNA vaccines durably boost neutralizing antibodies and mitigate ancestral immune imprinting
Ian A Mellis, Madeline Wu, Hsiang Hong, et al.
Nature Communications
|
October 5, 2023
Viral kinetics of sequential SARS-CoV-2 infections
Stephen M Kissler, James A Hay, Joseph R Fauver, et al.
Biorxiv : the Preprint Server for Biology
|
March 10, 2021
Increased Resistance of SARS-CoV-2 Variant P.1 to Antibody Neutralization
Pengfei Wang, Ryan G Casner, Manoj S Nair, et al.
Cell Host & Microbe
|
April 22, 2021
Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization
Pengfei Wang, Ryan G Casner, Manoj S Nair, et al.
Cell Reports
|
April 9, 2025
Antibody evasiveness of SARS-CoV-2 subvariants KP.3.1.1 and XEC
Qian Wang, Yicheng Guo, Ian A Mellis, et al.
Page
of 25
Search research articles
Search
Showing results (91-100 of 241) with videos related to
Sort By:
Page
of 25
Nature
|
March 26, 2005
Recognition of bacterial glycosphingolipids by natural killer T cells
Yuki Kinjo, Douglass Wu, Gisen Kim, et al.
Journal of Virology
|
November 5, 2020
Dual Pathways of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trafficking Modulate the Selective Exclusion of Uncleaved Oligomers from Virions
Shijian Zhang, Hanh T Nguyen, Haitao Ding, et al.
Plos Biology
|
March 14, 2024
Developing inhibitory peptides against SARS-CoV-2 envelope protein
Ramsey Bekdash, Kazushige Yoshida, Manoj S Nair, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2026
LP.8.1-directed COVID-19 mRNA vaccines durably boost neutralizing antibodies and mitigate ancestral immune imprinting
Ian A Mellis, Madeline Wu, Hsiang Hong, et al.
Journal of Virology
|
November 20, 2002
Human immunodeficiency virus type 1 (HIV-1)-specific CD8+-T-cell responses for groups of HIV-1-infected individuals with different HLA-B*35 genotypes
Xia Jin, Xiaojiang Gao, Murugappan Ramanathan, et al.
Plos Pathogens
|
May 11, 2026
LP.8.1-directed COVID-19 mRNA vaccines durably boost neutralizing antibodies and mitigate ancestral immune imprinting
Ian A Mellis, Madeline Wu, Hsiang Hong, et al.
Nature Communications
|
October 5, 2023
Viral kinetics of sequential SARS-CoV-2 infections
Stephen M Kissler, James A Hay, Joseph R Fauver, et al.
Biorxiv : the Preprint Server for Biology
|
March 10, 2021
Increased Resistance of SARS-CoV-2 Variant P.1 to Antibody Neutralization
Pengfei Wang, Ryan G Casner, Manoj S Nair, et al.
Cell Host & Microbe
|
April 22, 2021
Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization
Pengfei Wang, Ryan G Casner, Manoj S Nair, et al.
Cell Reports
|
April 9, 2025
Antibody evasiveness of SARS-CoV-2 subvariants KP.3.1.1 and XEC
Qian Wang, Yicheng Guo, Ian A Mellis, et al.
Page
of 25